<I>In vitro</I> activity of quinolones and macrolides against <I>Mycobacterium avium</I> complex:a comparison of isolate susceptibility in two general hospitals and one tuberculosis sanatorium located in the same area of Japan

In vitro activity of quinolones and macrolides against Mycobacterium avium complex:a comparison of isolate susceptibility in two general hospitals and one tuberculosis sanatorium located in the same area of Japan

Y. Shibuya, N. Uemura, Y. Seo, S. Nakamura, H. Kurusu (Tokyo, Tochigi, Japan)

Source: Annual Congress 2003 - Management of tuberculosis

Session: Management of tuberculosis
Session type: Thematic Poster Session
Number: 3246

Disease area: Respiratory infections

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Shibuya, N. Uemura, Y. Seo, S. Nakamura, H. Kurusu (Tokyo, Tochigi, Japan). In vitro activity of quinolones and macrolides against Mycobacterium avium complex:a comparison of isolate susceptibility in two general hospitals and one tuberculosis sanatorium located in the same area of Japan. Eur Respir J 2003; 22: Suppl. 45, 3246

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Estimation of susceptibility hospital strains of Mycobacterium tuberculosis (Mtb) Beijing to disinfectants Source: International Congress 2017 – Paediatric TB: MDRTB (II) Year: 2017
Does Mycobacterium bovis appear among the clinical Mycobacterium tuberculosis complex isolates from TB patients of university hospital in Warsaw between 1999 and 2007? Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III Year: 2008
High incidence of the Beijing strains among multi drug resistance isolates of Mycobacterium tuberculosis from extra pulmonary tuberculosis cases in northern India Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012
Molecular analysis of mutations in genes associated with multidrug-resistance in Mycobacterium tuberculosis isolates from patients with tuberculosis in Moscow region, Russia Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018
Determination of DNA fingerprint and drug susceptibility patterns of Mycobacterium tuberculosis isolates from a designated area in north India Source: Annual Congress 2009 - Diagnostic advances in tuberculosis Year: 2009
Molecular characterization of mycobacterium tuberculosis resistant to fluoroquinolones, distributed in Saratov region Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools Year: 2012
DNA fingerprint analysis of Mycobacterium tuberculosis complex strains isolated from homeless tuberculosis patients in Budapest Source: Eur Respir J 2004; 24: Suppl. 48, 424s Year: 2004
Resistance genotypes of multidrug-resistant Mycobacterium tuberculosis isolates in Serbia Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019
Hospital-based antibiotic use in patients with Mycobacterium avium complex Source: ERJ Open Res, 4 (4) 00109-2018; 10.1183/23120541.00109-2018 Year: 2018
Drug resistance pattern of mycobacterium tuberculosis complex at the main reference tuberculosis centre in Greece, 2000-2010 Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2011
Drug resistance trends and patterns of mycobacterium tuberculosis isolates from pulmonary tuberculosis patients at a tertiary care hospital in Turkey Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences Year: 2012
Characteristics of drug susceptibility testing for bedaquline and clofazimine of 178 drug-resistant Mycobacterium tuberculosis isolates in Japan Source: International Congress 2019 – Drug-resistant tuberculosis Year: 2019
Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019
Mycobacterium tuberculosis drug resistance surveillance in Belarus Source: Eur Respir J 2005; 26: Suppl. 49, 199s Year: 2005
Multidrug resistance of M. tuberculosis and its infuence on treatment efficiency of new detected patients with pulmonary tuberculosis in penitentiary institutions of Belarus Source: Eur Respir J 2007; 30: Suppl. 51, 272s Year: 2007
Evaluation of macrolides for possible use against multidrug-resistant Mycobacterium tuberculosis Source: Eur Respir J 2015; 46: 444-455 Year: 2015
Susceptibility of Mycobacterium tuberculosis strains to fluoquinolones, obtained from chronic patients with multidrug resistant pulmonary tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 315s Year: 2001
The Glutoxim influence on minimum inhibitory concentration of isoniazid-resistant strains of Mycobacterium tuberculosis Source: International Congress 2019 – Tuberculosis: from basic science to patient care Year: 2019
Genetic diversity of M. tuberculosis isolates from patients with drug-resistant TB in Japan Source: International Congress 2018 – Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity Year: 2018
In vitro susceptibility testing of bedaquiline against mycobacteria avium-intracellulare complex Source: Virtual Congress 2020 – Aspergillosis and chronic lung infections Year: 2020